01/23/2026
THIS ISN’T A COINCIDENCE.
🎥 Watch for context, clarity, and the bigger picture.
GLP-1 use is rising, and the data is starting to show real shifts.
In this expert breakdown, OrderlyMeds advisor and Cleveland Clinic trained Registered Dietitian Kristin Kirkpatrick walks through new findings that point to a meaningful change since 2022.
The data shows two things happening at once:
🔹 U.S. obesity rates declining
🔹 GLP-1 use doubling, with women ages 40 to 60 leading the way
Kristin explains what’s driving this shift, what it means for long-term health, and why medication alone is never the full picture.
Sustainable progress comes from support.
That includes nutrition guidance, thoughtful dosing, movement, and mental health care that fits real life.
This is the kind of whole-person care OrderlyMeds is built around.